Altered Pharmacokinetics of Voriconazole in a Patient with Liver Cirrhosis
- 1 September 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (9) , 3459-3460
- https://doi.org/10.1128/aac.00791-07
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Voriconazole Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2006
- Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infectionsJournal of Antimicrobial Chemotherapy, 2006
- Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test AbnormalitiesThe Journal of Clinical Pharmacology, 2006
- 120 Monitoring of voriconazole (VRC) blood levels for prevention of serious neurological adverse events (SNAE)International Journal of Infectious Diseases, 2006
- Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trialThe Lancet, 2005
- Isocratic High-Performance Liquid Chromatographic Method with Ultraviolet Detection for Simultaneous Determination of Levels of Voriconazole and Itraconazole and Its Hydroxy Metabolite in Human SerumAntimicrobial Agents and Chemotherapy, 2005
- THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMANDrug Metabolism and Disposition, 2003
- The Safety of VoriconazoleClinical Infectious Diseases, 2002
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002